A study reported that EpCAM overexpression was significantly correlated with 5-year worse biochemical recurrence free-survival using multivariate Cox proportional-hazards regression analysis (HR = 6.79, 95% CI = 2.38–19.45) in 102 patients with PCa [23]. This evidence concerns the gene EPCAM and posterior cortical atrophy.